Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Galapagos and Opsona Therapeutics initiate drug discovery collaboration
June 2009
SHARING OPTIONS:

MECHELEN, BelgiumóGalapagos NV announced in May that it has entered into a drug discovery partnership with Opsona Therapeutics in Dublin, Ireland. Under the terms of the agreement, Galapagos' service division BioFocus DPI will perform biology, medicinal chemistry and ADME/PK services for an Opsona drug discovery program.  Opsona will make research payments to BioFocus DPI and fund the work of four to five BioFocus DPI scientists in 2009. Financial terms of the deal were not disclosed.

"We are pleased to add Opsona Therapeutics, an emerging biotech with a promising pipeline and a successful follow-on financing round, to the growing list of BioFocus DPI customers," says Onno van de Stolpe, CEO of Galapagos.
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.